BioCentury
ARTICLE | Company News

Idenix management update

November 1, 2010 7:00 AM UTC

Idenix Pharmaceuticals Inc. (NASDAQ:IDIX), Cambridge, Mass. Business: Infectious Resigned: Jean-Pierre Sommadossi as president, CEO and chairman Transitioned: Ronald Renaud to president, CEO and a dir...